Itonic Holdings Ltd. (NASDAQ:ITOC) Stock Short Interest Report for October

Itonic Holdings Ltd. (NASDAQ:ITOC) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 10,047 shares, a decline of 95.1% from the September 30th total of 206,400 shares. Based on an average trading volume of 26,939 shares, the short-interest ratio is presently 0.4 days. Approximately 0.1% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, September 24th. One analyst has rated the stock with a Sell rating. According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Itonic Stock Down 9.6%

Shares of NASDAQ ITOC traded down $0.27 during trading hours on Monday, reaching $2.53. The stock had a trading volume of 42,679 shares, compared to its average volume of 21,468. The firm has a 50-day moving average of $4.46 and a 200-day moving average of $4.97. Itonic has a fifty-two week low of $2.33 and a fifty-two week high of $18.40.

Itonic (NASDAQ:ITOC) last released its quarterly earnings results on Wednesday, September 30th. The company reported ($0.75) EPS for the quarter. The business had revenue of $0.05 million during the quarter.

Itonic Company Profile

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.